Abstract
Osteoarticular complications may occur with a variety of invasive fungal infections, and seem to be increasing with growing use of prosthetic joints and as the immunosuppressed patient population increases. Epidemiology, pathogenesis, presentation, and management strategies differ somewhat among the different fungal species. This review focuses on recent developments in diagnostic and management approaches for patients with osteoarticular mycoses, and outlines specific treatment strategies for the different species.
Similar content being viewed by others
References and Recommended Reading
Pfaller MA, Lockhart SR, Pujol C, et al. Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates. J Clin Microbiol 1998, 36:1518–1529.
Zmierczak H, Goemaere S, Mielants H, et al. Candida glabrata arthritis: case report and review of the literature of Candida arthritis. Clin Rheumatol 1999, 18:406–409.
Miller DJ, Mejicano CG, Vertebral osteomyelitis due to Candida species: case report and literature review. Clin Infect Dis 2001, 33:523–530. Review of 59 published cases of candidal vertebral osteomyelitis including epidemiology, presentation, diagnosis, and management.
Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989. National Nosocomial Infections Surveillance System. Am J Med 1991, 91:86S-89S.
Cuellar ML, Silveira LH, Espinoza LR, Fungal arthritis. Ann Rheum Dis 1992, 51:690–697.
Perez-Gomez A, Prieto A, Torresano M, et al. Role of the new azoles in the treatment of fungal osteoarticular infections. Semin Arthritis Rheum 1998, 27:226–244.
Jonnalagadda S, Veerabagu MP, Rakela J, et al. Candida albicans osteomyelitis in a liver transplant recipient: a case report and review of the literature. Transplantation 1996, 62:1182–1184.
Corso FA, Shaul DB, Wolfe BM, Spinal osteomyelitis after TPN catheter-induced septicemia. Jpen J Parenteral Enteral Nutr 1995, 19:291–295.
Ferra C, Doebbeling BN, Hollis RJ, et al. Candida tropicalis vertebral osteomyelitis: a late sequela of fungemia. Clin Infect Dis 1994, 19:697–703.
Edelstein H, McCabe R, Candida albicans septic arthritis and osteomyelitis of the sternoclavicular joint in a patient with human immunodeficiency virus infection. J Rheumatol 1991, 18:110–111.
Lafont A, Olive A, Gelman M, et al. Candida albicans spondylodiscitis and vertebral osteomyelitis in patients with intravenous heroin drug addiction. Report of 3 new cases. J Rheumatol 1994, 21:953–956.
Goodman JS, Seibert DG, Reahl GE Jr, Geckler RW, Fungal infection of prosthetic joints: a report of two cases. J Rheumatol 1983, 10:494–495.
Hansen BL, Andersen K, Fungal arthritis. A review. Scand J Rheumatol 1995, 24:248–250.
Clancy CJ, Nguyen MH, Morris AJ, Candidal mediastinitis: an emerging clinical entity. Clin Infect Dis 1997, 25:608–613.
Gathe JC Jr, Harris RL, Garland B, et al. Candida osteomyelitis. Report of five cases and review of the literature. Am J Med 1987, 82:927–937.
Eisen DP, MacGinley R, Christensson B, et al. Candida tropicalis vertebral osteomyelitis complicating epidural catheterisation with disease paralleled by elevated D-arabinitol/L-arabinitol ratios. Eur J Clin Microbiol Infect Dis 2000, 19:61–63.
Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 2000, 30:662–678. Recommendations from an expert panel of practitioners and the IDSA for management of invasive candidiasis.
Brooks DH, Pupparo F, Successful salvage of a primary total knee arthroplasty infected with Candida parapsilosis. J Arthroplasty 1998, 13:707–712.
Hibberd PL, Rubin RH, Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis 1994, 19,suppl 40,:S33-S40.
Bayer AS, Guze LB, Fungal arthritis. I. Candida arthritis: diagnostic and prognostic implications and therapeutic considerations. Semin Arthritis Rheum 1978, 8:142–150.
Flanagan PG, Barnes RA, Hazards of inadequate fluconazole dosage to treat deep-seated or systemic Candida albicans infection. J Infection 1997, 35:295–297.
Fischman AJ, Alpert NM, Livni E, et al. Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography. Antimicrob Agents Chemother 1993, 37:1270–1277.
O’Meeghan T, Varcoe R, Thomas M, Ellis-Pegler R, Fluconazole concentration in joint fluid during successful treatment of Candida albicans septic arthritis. J Antimicrob Chemother 1990, 26:601–602.
Weers-Pothoff G, Havermans JF, Kamphuis J, et al. Candida tropicalis arthritis in a patient with acute myeloid leukemia successfully treated with fluconazole: case report and review of the literature. Infection 1997, 25:109–111.
Tang C, Successful treatment of Candida albicans osteomyelitis with fluconazole. J Infection 1993, 26:89–92.
Sugar AM, Saunders C, Diamond RD, Successful treatment of Candida osteomyelitis with fluconazole. A noncomparative study of two patients. Diagn Microbiol Infect Dis 1990, 13:517–520.
Arranz-Caso JA, Lopez-Pizarro VM, Gomez-Herruz P, et al. Candida albicans osteomyelitis of the zygomatic bone. A distinctive case with a possible peculiar mechanism of infection and therapeutic failure with fluconazole. Diagn Microbiol Infect Dis 1996, 24:161–164.
Dan M, Priel I, Failure of fluconazole therapy for sternal osteomyelitis due to Candida albicans. Clin Infect Dis 1994, 18:126–127.
Swanson H, Hughes PA, Messer SA, et al. Candida albicans arthritis one year after successful treatment of fungemia in a healthy infant. J Pediatr 1996, 129:688–694.
Yousefzadeh DK, Jackson JH, Neonatal and infantile candidal arthritis with or without osteomyelitis: a clinical and radiographical review of 21 cases. Skeletal Radiol 1980, 5:77–90.
Harris MC, Pereira GR, Myers MD, et al. Candidal arthritis in infants previously treated for systemic candidiasis during the newborn period: report of three cases. Pediatr Emerg Care 2000, 16:249–251.
Miller MJ, Infectious Diseases of the Fetus and Newborn Infant, Philadelphia: WB Saunders; 1995.
Behrman RE, Masci JR, Nicholas P, Cryptococcal skeletal infections: case report and review. Rev Infect Dis 1990, 12:181–190. Review of 39 published case reports of cryptococcal osteomyelitis.
Casadevall A, Perfect JR, Cryptococcus neoformans, Washington, DC: American Society for Microbiology; 1998.
Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000, 30:710–718.
Perez-Gomez A, Prieto A, Torresano M, et al. Role of the new azoles in the treatment of fungal osteoarticular infections. Semin Arthritis Rheum 1998, 27:226–244.
Galgiani JNM, Catanzaro AM, Cloud GAM, et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis: a randomized, doubleblind trial. Ann Intern Med 2000, 133:676–686. Clinical trial comparing itraconazole and fluconazole for treatment of nonmeningeal disseminated coccidioidomycosis.
Galgiani JNM, Coccidioides immitus. In Principles and Practices of Infectious Diseases, edn 5. Edited by Mandell GL, Bennett JE, Dolin R, Philadelphia: Churchill Livingstone; 2000:2746–2755.
Schwarz J, What’s new in mycotic bone and joint diseases? Pathol Res Pract 1984, 178:617–634.
Rettig AC, Evanski PM, Waugh TR, Prietto CA, Primary coccidioidal synovitis of the knee: a report of four cases and review of the literature. Clin Orthopaed Related Res 1978, 187–192.
Galgiani JN, Ampel NM, Catanzaro A, et al. Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America. Clin Infect Dis 2000, 30:658–661. Recommendations from expert panel of practitioners and the IDSA for management of coccidioidomycosis.
Catanzaro A, Galgiani JN, Levine BE, et al. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group. Am J Med 1995, 98:249–256.
Saccente M, Abernathy RS, Pappas PG, et al. Vertebral blastomycosis with paravertebral abscess: report of eight cases and review of the literature. Clin Infect Dis 1998, 26:413–418. Report of findings among eight patients with vertebral blastomycosis and review of 12 published studies, with a focus on diagnosis and management.
Chapman SW, Blastomyces dermatitidis. In Principles and Practices of Infectious Diseases, edn 5. Edited by Mandell GL, Bennett JE, Dolin R, Philadelphia: Churchill Livingstone; 2000:2733–2744.
Chapman SW, Bradsher RW Jr, Campbell GD Jr, et al. Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America. Clin Infect Dis 2000, 30:679–683. Recommendations from expert panel of practitioners and the IDSA for management of blastomycosis.
Pappas PG, Bradsher RW, Kauffman CA, et al. Treatment of blastomycosis with higher doses of fluconazole. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis 1997, 25:200–205.
Li RK, Ciblak MA, Nordoff N, et al. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob Agents Chemother 2000, 44:1734–1736.
Centers for Disease Control and Prevention: Outbreak of acute respiratory febrile illness among college students--Acapulco, Mexico, March 2001. JAMA 2001, 285:2187.
Buck BE, Malinin TI, Davis JH, Transmission of histoplasmosis by organ transplantation. N Engl J Med 2001, 344:310.
Wheat J, Sarosi G, McKinsey D, et al. Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America. Clin Infect Dis 2000, 30:688–695. Recommendations from expert panel of practitioners and the IDSA for management of histoplasmosis.
Fowler VG Jr, Nacinovich FM, Alspaugh JA, Corey GR, Prosthetic joint infection due to Histoplasma capsulatum: case report and review. Clin Infect Dis 1998, 26:1017.
Johnson P, Wheat L, Cloud G, et al.: A multi-center randomized trial comparing amphotericin B and liposomal amphotericin B as induction therapy of disseminated histoplasmosis in AIDS patients [abstract]. Paper presented at Program and Abstracts of the 7th Conference on Retroviruses and Opportunistic Infections. January 30–February 2, 2000. San Francisco.
Kauffman CA, Hajjeh R, Chapman SW, Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America. Clin Infect Dis 2000, 30:684–687. Recommendations from expert panel of practitioners and the IDSA for management of sporotrichosis.
Downs NJ, Hinthorn DR, Mhatre VR, Liu C, Intra-articular amphotericin B treatment of Sporothrix schenckii arthritis. Arch Intern Med 1989, 149:954–955.
Kauffman CA, Pappas PG, McKinsey DS, et al. Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole. Clin Infect Dis 1996, 22:46–50.
Chan YF, Woo KC, Penicillium marneffei osteomyelitis. J Bone Joint Surg [Br] 1990, 72:500–503.
Pun TS, Fang D, A case of Penicillium marneffei osteomyelitis involving the axial skeleton. Hong Kong Med J 2000, 6:231–233.
Cohen-Abbo A, Edwards KM, Multifocal osteomyelitis caused by Paecilomyces varioti in a patient with chronic granulomatous disease. Infection 1995, 23:55–57.
Ziza JM, Dupont B, Boissonnas A, et al. Osteoarthritis caused by dematiaceous fungi. Apropos of 3 cases. Annales de Medecine Interne 1985, 136:393–397.
Brint JM, Flynn PM, Pearson TA, Pui CH, Disseminated fusariosis involving bone in an adolescent with leukemia. Pediatr Infect Dis J 1992, 11:965–968.
Piper JP, Golden J, Brown D, Broestler J,: Successful treatment of Scedosporium apiospermum suppurative arthritis with itraconazole. Pediatr Infect Dis J 1990, 9:674–675.
Hung LH, Norwood LA, Osteomyelitis due to Pseudallescheria boydii. South Med J 1993, 86:231–234.
Wood GM, McCormack JG, Muir DB, et al. Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis 1992, 14:1027–1033.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Johnson, M.D., Perfect, J.R. Fungal infections of the bones and joints. Curr Infect Dis Rep 3, 450–460 (2001). https://doi.org/10.1007/BF03160470
Issue Date:
DOI: https://doi.org/10.1007/BF03160470